- Home
- NCRA vs CARM Comparison
NCRA vs CARM Comparison
Compare NCRA & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- CARM
- Stock Information
- Founded
- NCRA 2002
- CARM 2016
- Country
- NCRA Taiwan
- CARM United States
- Employees
- NCRA N/A
- CARM N/A
- Industry
- NCRA Farming/Seeds/Milling
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- CARM Health Care
- Exchange
- NCRA Nasdaq
- CARM Nasdaq
- Market Cap
- NCRA 15.1M
- CARM 12.2M
- IPO Year
- NCRA N/A
- CARM N/A
- Fundamental
- Price
- NCRA $1.55
- CARM $0.24
- Analyst Decision
- NCRA
- CARM Hold
- Analyst Count
- NCRA 0
- CARM 5
- Target Price
- NCRA N/A
- CARM $0.90
- AVG Volume (30 Days)
- NCRA 33.6K
- CARM 447.9K
- Earning Date
- NCRA 08-14-2025
- CARM 08-07-2025
- Dividend Yield
- NCRA N/A
- CARM N/A
- EPS Growth
- NCRA N/A
- CARM N/A
- EPS
- NCRA N/A
- CARM N/A
- Revenue
- NCRA $13,865,984.00
- CARM $10,767,000.00
- Revenue This Year
- NCRA N/A
- CARM N/A
- Revenue Next Year
- NCRA N/A
- CARM N/A
- P/E Ratio
- NCRA N/A
- CARM N/A
- Revenue Growth
- NCRA N/A
- CARM N/A
- 52 Week Low
- NCRA $0.70
- CARM $0.14
- 52 Week High
- NCRA $2.09
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- NCRA 53.23
- CARM 31.94
- Support Level
- NCRA $1.56
- CARM $0.21
- Resistance Level
- NCRA $1.67
- CARM $0.31
- Average True Range (ATR)
- NCRA 0.09
- CARM 0.03
- MACD
- NCRA -0.03
- CARM -0.00
- Stochastic Oscillator
- NCRA 33.22
- CARM 23.64
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.